Share chart Adhera Therapeutics Inc
Extended chart
Simple chart
About
Adhera Therapeutics, Inc., a biotech company, focuses on the discovery, development, and commercialization of small molecule drugs. The company is developing MLR-1019 for the treatment of Parkinson's disease; and MLR -1023 to treat Type 1 diabetes. The company was formerly known as Marina Biotech, Inc. and changed its name to Adhera Therapeutics, Inc. in October 2018. Adhera Therapeutics, Inc. is based in Baton Rouge, Louisiana.
| ISIN |
US00687E1091 |
| Industry |
Biotechnology |
| Sector |
Health Care |
| Валюта |
usd |
| Валюта отчета |
usd |
| Сайт |
https://adherathera.com
|
| Цена ао |
0.0001 |
| Change price per day: |
0% (0.0001) |
| Change price per week: |
0% (0.0001) |
| Change price per month: |
-98.75% (0.008) |
| Change price per 3 month: |
-96.77% (0.0031) |
| Change price per half year: |
-99% (0.01) |
| Change price per year: |
-99.5% (0.02) |
| Change price per 3 year: |
-99.91% (0.11) |
| Change price per 5 year: |
-99.93% (0.15) |
| Change price per 10 year: |
0% (0.0001) |
| Change price per year to date: |
0% (0.0001) |
|
|
Underestimation
| Title |
Value |
Grade |
| P/S |
0 |
0 |
| P/BV |
0 |
0 |
| P/E |
0 |
0 |
| EV/EBITDA |
0 |
0 |
| Total: |
|
2.5 |
|
Efficiency
| Title |
Value |
Grade |
| ROA, % |
0 |
0 |
| ROE, % |
0 |
0 |
| Total: |
|
0 |
|
|
|
Dividends
| Title |
Value |
Grade |
| Div yield, % |
0 |
0 |
| DSI |
0 |
0 |
| Total: |
|
0.56 |
|
Debt
| Title |
Value |
Grade |
| Debt/EBITDA |
0 |
10 |
| Total: |
|
10 |
|
Growth impulse
| Title |
Value |
Grade |
| Yield Revenue, % |
-96.87 |
0 |
| Yield Ebitda, % |
-85.42 |
0 |
| Yield EPS, % |
-8.94 |
0 |
| Total: |
|
0 |
|
| Head |
Job title |
Payment |
Year of birth |
| Mr. Andrew Albert Kucharchuk M.B.A. |
Vice Chairman, COO, Acting CFO & Chief Business Officer |
|
1981 (44 years) |
